- Joined
- May 29, 2023
- Messages
- 7
- Likes
- 1
- Points
- 0
Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies.
Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:
Target Indication(s)
Melanoma
Head and Neck Carcinoma
Chronic Lymphocytic Leukemia
Sarcoma
Hepatocellular Carcinoma
Breast Cancer
Acute Myeloid Leukemia
Cervical Carcinoma
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
The Global TIL Therapy Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. TIL-based Therapies: Market Landscape
5. Clinical Trial Analysis
6. Key Opinion Leaders
7. TIL-based Therapy Profiles
8. Partnerships And Collaborations
9. Funding And Investment Analysis
10. Patent Analysis
11. Case Study: Cell Therapy Manufacturing
12. Cost Price Analysis
13. Market Forecast and Opportunity Analysis
14. Company Profiles
15. Concluding Remarks
16. Executive Insights
17. Appendix I: Tabulated Data
18. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market
Global Antibiotics Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#TILTherapiesMarketSize #TILTherapiesMarketGrowth #TILimmunotherapies #TILbasedproducts #TILMarket
Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:
Target Indication(s)
Melanoma
Head and Neck Carcinoma
Chronic Lymphocytic Leukemia
Sarcoma
Hepatocellular Carcinoma
Breast Cancer
Acute Myeloid Leukemia
Cervical Carcinoma
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
The Global TIL Therapy Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
- Cellectis
- Cellular Biomedicine Group
- Iovance Biotherapeutics
- Lytix Biopharma
- Phio Pharmaceuticals
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. TIL-based Therapies: Market Landscape
5. Clinical Trial Analysis
6. Key Opinion Leaders
7. TIL-based Therapy Profiles
8. Partnerships And Collaborations
9. Funding And Investment Analysis
10. Patent Analysis
11. Case Study: Cell Therapy Manufacturing
12. Cost Price Analysis
13. Market Forecast and Opportunity Analysis
14. Company Profiles
15. Concluding Remarks
16. Executive Insights
17. Appendix I: Tabulated Data
18. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market
Global Antibiotics Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#TILTherapiesMarketSize #TILTherapiesMarketGrowth #TILimmunotherapies #TILbasedproducts #TILMarket
